![Lisa Dalton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lisa Dalton
Nessuna posizione attualmente
Patrimonio netto: 517 $ in data 31/07/2023
Profilo
Lisa Dalton served as the Head of Human Resources at Spark Therapeutics, Inc. from 2014 to 2019.
Prior to that, she was the Vice President of Human Resources at Shire Pharmaceuticals, Inc. She also served as an Independent Director at Nabriva Therapeutics Plc from 2021 to 2023.
Dalton received an undergraduate degree from The Pennsylvania State University and an MBA from Rutgers Business School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
NABRIVA THERAPEUTICS PLC
0.01% | 31/01/2023 | 364 ( 0.01% ) | 517 $ | 31/07/2023 |
Precedenti posizioni note di Lisa Dalton
Società | Posizione | Fine |
---|---|---|
NABRIVA THERAPEUTICS PLC | Direttore/Membro del Consiglio | 30/07/2023 |
Shire Pharmaceuticals, Inc.
![]() Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Ufficiale delle Risorse Umane | - |
SPARK THERAPEUTICS, INC. | Ufficiale delle Risorse Umane | - |
Formazione di Lisa Dalton
The Pennsylvania State University | Undergraduate Degree |
Rutgers Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NABRIVA THERAPEUTICS PLC | Health Technology |
Aziende private | 2 |
---|---|
Spark Therapeutics, Inc.
![]() Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Shire Pharmaceuticals, Inc.
![]() Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
- Borsa valori
- Insiders
- Lisa Dalton